文献速递冠心病心力衰竭与心肌病瓣膜病与结构性心脏病

左心室血栓风险与患者的美国心脏协会科学声明解读

Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.
PubMed 文献 · Circulation · 2022-09-15

该美国心脏协会科学声明针对左心室血栓的8个关键临床管理问题,基于对实际研究数据的严格审查,由多学科写作委员会提出实践管理建议,涵盖心肌梗死后预防与治疗、扩张型心肌病、附壁血栓、影像学、直接口服抗凝药替代华法林、非口服抗凝治疗及持续血栓的处理。

要点

  • 声明聚焦左心室血栓诊断、预防和治疗的8个关键临床问题。
  • 直接口服抗凝药可作为华法林替代选项,但需结合具体临床情境。
  • 心脏磁共振对左心室血栓检测敏感性高于超声心动图。

核心结论

  • 针对左心室血栓管理的8个关键临床问题,声明基于实际研究数据提出实践管理建议。

研究设计与样本

  • 美国心脏协会委托多学科写作委员会制定科学声明,基于对实际研究数据的严格审查。

主要发现

  • 当前指南对左心室血栓的组织性推荐有限,临床管理问题日益复杂。
  • 管理难题包括双联抗血小板治疗基础上加用口服抗凝药、直接口服抗凝药作为华法林替代选项以及心脏磁共振的应用。

临床怎么用

  • 声明以文本、表格和流程图形式提供左心室血栓的实践管理建议。
  • 管理建议涵盖心肌梗死后和扩张型心肌病中的预防与治疗、附壁血栓处理、影像学检查、直接口服抗凝药使用、非口服抗凝治疗及持续血栓的应对。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the many advances in cardiovascular medicine, decisions concerning the diagnosis, prevention, and treatment of left ventricular (LV) thrombus often remain challenging. There are only limited organizational guideline recommendations with regard to LV thrombus. Furthermore, management issues in current practice are increasingly complex, including concerns about adding oral anticoagulant therapy to dual antiplatelet therapy, the availability of direct oral anticoagulants as a potential alternative option to traditional vitamin K antagonists, and the use of diagnostic modalities such as cardiac magnetic resonance imaging, which has greater sensitivity for LV thrombus detection than echocardiography. Therefore, this American Heart Association scientific statement was commissioned with the goals of addressing 8 key clinical management questions related to LV thrombus, including the prevention and treatment after myocardial infarction, prevention and treatment in dilated cardiomyopathy, management of mural (laminated) thrombus, imaging of LV thrombus, direct oral anticoagulants as an alternative to warfarin, treatments other than oral anticoagulants for LV thrombus (eg, dual antiplatelet therapy, fibrinolysis, surgical excision), and the approach to persistent LV thrombus despite anticoagulation therapy. Practical management suggestions in the form of text, tables, and flow diagrams based on careful and critical review of actual study data as formulated by this multidisciplinary writing committee are given.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Levine GN, McEvoy JW, Fang JC, et al. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022. PMID: 36106537. doi:10.1161/CIR.0000000000001092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。